Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FD06C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,570
Award facts
- Contract value 100% obligated
- $16,570.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,570.04 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Wegovy 1.7 mg/0.75 mL pen injectors. The contract, classified as firm fixed price with no set-aside designation, is scheduled for completion by September 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle (SPE2DX) extending through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company has demonstrated its competitiveness through numerous non-set-aside awards with the Defense Logistics Agency and maintains relationships with the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular award for Wegovy, a GLP-1 receptor agonist diabetes medication, reflects AmerisourceBergen's role in supporting military personnel healthcare needs through the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FD06C?
SPE2DB25FD06C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FD06C worth?
The government has obligated $16,570 on SPE2DB25FD06C.
Is contract SPE2DB25FD06C an order under another contract?
Yes. SPE2DB25FD06C is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FD06C competed?
The extent of competition for SPE2DB25FD06C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award